Observational studyMedicine2025
Association between red blood cell distribution width-to-albumin ratio and cardiovascular disease mortality and all-cause mortality in patients with hypertension: An observational study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of red cell distribution width-to-albumin ratio with mortality in adults with low muscle mass: A retrospective cohort study.The Journal of international medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the relationship between red blood cell distribution width to-albumin ratio (RAR) and mortality risk among patients with hypertension, thereby providing a foundation for early assessment in this population. A total of 6830 adult patients with hypertension were included in this study. To explore the association between RAR levels and 10-year all-cause mortality in patients with hypertension, smooth curve fitting and Kaplan-Meier (KM) curve analysis were employed. Additionally, Cox regression analysis was conducted to evaluate the impact of RAR on all-cause mortality. The robustness of the findings was confirmed through stratified analysis and interaction tests. A competing risk model was also utilized to assess the relationship between RAR and cardiovascular as well as cerebrovascular mortality in patients with hypertension. The result of smooth curve fitting showed that 10-year all-cause mortality rate among patients with hypertension progressively increased with higher RAR levels. After fully adjusting for confounding factors, RAR remained significantly associated with a 10-year all-cause mortality risk in patients with hypertension (HR = 1.69, 95% confidence interval: 1.50-1.8, P < .001). Furthermore, the competing risk model revealed a similar association between RAR and both cardiovascular and cerebrovascular mortality in this group. With RAR levels rise, the risk of all-cause mortality and mortality due to cardiovascular disease also escalates. This study suggest that RAR may serve as a useful tool for assessing the prognosis of patients with hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.